Related Experiment Video
Updated: Jul 8, 2026

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Calcium and cardiomyopathies
1Department of Pharmacology & Cell Biophysics, College of Medicine,University of Cincinnati, OH 45267-0575, USA. Litsa.kranias@uc.edu
Insights
Sarcoplasmic reticulum (SR) proteins regulate cardiac calcium (Ca) cycling, essential for heart function. Genetic variants in these proteins are linked to heart failure and arrhythmias.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Cardiac excitation-contraction (E-C) coupling relies on sarcoplasmic reticulum (SR) calcium (Ca) cycling.
- Dysfunctional Ca cycling in the SR network characterizes cardiac hypertrophy and heart failure.
- Key SR Ca-handling proteins include SERCA, phospholamban (PLN), calsequestrin, and the ryanodine receptor (RyR).
Purpose of the Study:
- To review the critical role of SR Ca-cycling proteins in cardiac health and disease.
- To highlight recent findings on genetic modifiers of SR Ca-cycling proteins.
Main Methods:
- Review of existing literature on SR Ca-cycling proteins.
- Focus on genetic variants and their impact on cardiomyopathies.
- Analysis of protein function in cardiac relaxation, Ca-load, and Ca-release.
Main Results:
- Altered levels or activity of SERCA, PLN, calsequestrin, and RyR are observed in cardiomyopathies.
- These alterations correlate with impaired cardiac function and remodeling.
- Genetic variations in SR Ca-cycling proteins can predispose individuals to heart failure and arrhythmias.
Conclusions:
- SR Ca-cycling proteins are pivotal in maintaining cardiac function.
- Dysregulation and genetic variants of these proteins are implicated in heart disease pathogenesis.
- Understanding these proteins and their genetic modifiers is crucial for diagnosing and treating cardiomyopathies.
Abstract:
Regulation of Calcium (Ca) cycling by the sarcoplasmic reticulum (SR) underlies the control of cardiac contraction during excitation-contraction (E-C) coupling. Moreover, alterations in E-C coupling occurring in cardiac hypertrophy and heart failure are characterized by abnormal Ca-cycling through the SR network. A large body of evidence points to the central role of: a) SERCA and its regulator phospholamban (PLN) in the modulation of cardiac relaxation; b) calsequestrin in the regulation of SR Ca-load; and c) the ryanodine receptor (RyR) Ca-channel in the control of SR Ca-release. The levels or activity of these key Ca-handling proteins are altered in cardiomyopathies, and these changes have been linked to the deteriorated cardiac function and remodeling. Furthermore, genetic variants in these SR Ca-cycling proteins have been identified, which may predispose to heart failure or fatal arrhythmias. This chapter concentrates on the pivotal role of SR Ca-cycling proteins in health and disease with specific emphasis on their recently reported genetic modifiers.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myocarditis I: Introduction

